Individuals should be listed as authors only if they
(1) made a substantial contribution to the conception and design of the study, the acquisition of the data used in the study, or the analysis and interpretation of that data; (2) were involved in drafting or revising the manuscript critically for important intellectual content; and
(3) approved the submitted version of the manuscript and will have an opportunity to approve subsequent revisions of the manuscript, including the version to be published.
All 3 conditions must be met. Each individual listed as an author must have participated sufficiently to take public responsibility for the work. Acquisition of funding, collection of data, or general supervision of the research team does not, alone, justify authorship.
A manuscript is received with the understanding that the information has not been published or submitted for publication in any compiled printed (eg, journals, symposia, proceedings, newsletters, or books) or electronic (eg, websites, CD-ROMs, DVDs, or blogs) format in English or any other language and will not be published or submitted for publication elsewhere while the manuscript is under consideration by TJVR. Any exceptions must be clearly described at the time of manuscript submission.
A manuscript containing previously published information may be rejected on the grounds of prior publication. Publication of abstracts containing less than 250 words will not be considered to constitute prior publication, but publication of longer abstracts may be. Authors are encouraged to consult the guidelines for preparation of scientific abstracts when preparing scientific abstracts for publication. In general, figures, tables, footnotes, and references should not be included in abstracts.
At the time of manuscript submission, the corresponding author must include copies of any abstracts of the manuscript that have been published or submitted for publication or that are expected to be submitted for publication, along with copies of any closely related manuscripts or manuscripts with substantially similar content.
The Editor-in-Chief has the discretion to reject the manuscript straight off before or after sending it to the reviewers for reviewing.
TJVR is covered by copyright. All authors will be required to transfer copyright to the editorial board prior to publication of any manuscript or letter. Requests to copy, reprint, or use portions of published material (including information in figures and tables) should be addressed to the editor-in-chief.
Authors must obtain and submit a statement of permission from the copyright holder (most often, the author or publisher) if they wish to include items such as figures, tables, or appendices that appeared or will have appeared in other published reports prior to publication of the manuscript, regardless of the originating source.
Original artwork (eg, drawings or photographs) that was created specifically for use in the manuscript must be accompanied by a letter explaining the conditions under which the work was created. The letter must be signed by the artist and specify the rights given to the authors for use of the artwork and the rights retained by the artist (if any). If rights are retained by the artist, the letter must include a statement that allows the journal to use the material for publication in print and online.
Funding and Support
All funding, other financial support (eg, grant support), and material support (eg, provision of equipment or supplies) received directly or indirectly (via an author’s institution) from any third party (eg, any government agency, foundation, or commercial enterprise) in connection with the study or writing of the manuscript must be clearly and completely described in theAcknowledgments section of the manuscript. If no third-party funding or support was received, the following statement or an equivalent may be included:
No third-party funding or support was received in connection with this study or the
writing or publication of the manuscript.
The authors must also include a relevant statement in the Acknowledgments section if any funding organization or sponsor had any role in the design or conduct of the study; collection, analysis, or interpretation of the data; writing or approval of the manuscript; or decision to submit the manuscript for publication. Alternatively, the following statement or an equivalent may be included:
Funding sources did not have any involvement in the study design, data analysis and
interpretation, or writing and publication of the manuscript.
Failure to fully disclose sources of financial and other support may be grounds for rejection or retraction of the manuscript.
Conflicts of Interest and Financial Disclosures
A conflict of interest exists whenever an individual has financial interests or personal relationships that might consciously or unconsciously influence his or her decisions. Conflicts of interest are ubiquitous and cannot be completely eliminated; they do not, by themselves, indicate improper behavior, wrongdoing, or scientific misconduct.
Financial relationships are the most easily identifiable conflicts of interest and include, among other things, ownership, employment, consultancies, honoraria, paid expert testimony, grants, patents, stock ownership or options, and service as an officer or board member. Other types of conflicts of interest include personal relationships, academic competition, and intellectual beliefs.
All authors must disclose in the Acknowledgments section of the manuscript any financial or personal relationships that could be perceived to influence or could give the appearance of influencing information in the submitted manuscript. This includes detailed information about all relevant financial interests, activities, relationships, and affiliations (other than affiliations listed on the title page of the manuscript) occurring at the present time or within the 3 years prior to manuscript submission. In this context, relevant financial interests, activities, relationships, and affiliations should be interpreted broadly. For example, authors should disclose relationships they have not only with companies that manufacture products that are the subject of research described in the manuscript but also with companies that manufacture competing products. If no such conflicts of interest existed, the following statement or an equivalent may be included:
The authors declare that there were no conflicts of interest.
The editors reserve the right to reject any manuscript because of conflicts of interest. Failure to fully disclose conflicts of interest may be grounds for rejection or retraction of the manuscript.
Humane Animal Care and Use
To be considered for publication in TJVR, all research studies involving animals must have been performed in compliance with guidelines outlined in the Animal Welfare Act (http://awic.nal.usda.gov/government-and-professional-resources/federal-laws/animal- welfare-act), US Public Health Service Policy on the Humane Care and Use of Laboratory Animals (http://grants.nih.gov/grants/olaw/references/phspol.htm), National Research Council’s Guide for the Care and Use of Laboratory Animals (http://www.nap.edu/read/5140/chapter/1), or Guide for the Care and Use of Agricultural Animals in Research and Teaching (http://adsa.org/Publications/FASS2010AgGuide.aspx) or
in compliance with equivalent guidelines. If animals were euthanized, the method of euthanasia must be indicated in the manuscript. If a method not recommended, a justification for use of this method must be provided.
A manuscript containing information that suggests animals were subjected to adverse, stressful, or harsh conditions or treatments will not be considered for publication unless the authors demonstrate convincingly that the knowledge gained was of sufficient value to justify these conditions or treatments.
Publication of the accepted manuscripts is free of charge.
Original Research—An Original Research article is a research paper that provides new information derived from original data and usually includes extensive statistical analysis.Review Article—A Review Article is an in-depth analysis of the current status of a particular topic. It is not an original article with new data but represents a well-balanced summary of a timely subject with reference to the literature.
Technical Innovation—A Technical Innovation is a paper that describes a new method, procedure, technology, technique, or treatment with a practical approach.
Case Series—A Case Series is a paper that describes a group of cases or particular observations with unique imaging features or involving novel procedures. Case Series are usually retrospective and not associated with extensive statistical analysis.
Commentary—A Commentary is a short paper that describes the personal views of the author on a particular subject. It includes some review of the literature in making a point, although it is clearly an opinion piece rather than a review of the subject.
Letter to the Editor—A Letter to the Editor offers brief comments on published material and should be objective, constructive, and educational.
Clinical Letter—A Clinical Letter is a brief description of a single unique or unusual case. The manuscript should include a title, authors’ full names, degrees, and affiliations, a brief text description/discussion without headings, up to 10 references if applicable, and figure legends; note that each figure part (ie, Figure 1A or 1B) is counted as a separate image. No more than 4 images total may be included. It should not contain tables or data analysis. Clinical Letters are generally not peer reviewed and are published at the discretion of the editor based on space available; publication is not guaranteed.
Short Communication—A Short Communication article is a rather short paper reporting preliminary observations, new interpretations of old data, simple new techniques or devices, or points of historical interest.
ORGANIZATION OF THE MANUSCRIPT
Manuscripts should be organized in the following order, as applicable: title page, structured abstract or summary (when applicable; letters to the editor and review articles do not have a structured abstract), full text, acknowledgments, footnotes, references, tables, figure legends, and figures. All text elements and tables should be combined in a single document, double- spaced, with line numbering.
This first page should contain the complete title of the article, manuscript category, names and credentials of all authors, institutional affiliations of all authors, and a short running title (≤60 characters). The corresponding author should be indicated, including a complete mailing address, telephone number, and e-mail address.
Structured Abstract or Summary
An abstract is required for Original Research articles. The abstract should be divided into
Objectives, Animals (or Sample), Procedures, Results, and Conclusions and Clinical Relevance
sections. It should not exceed 250 words. Three to 6 key words should be provided at the end. The abstract should not contain figures, tables, or reference citations, trade names, or manufacturer names. Statements of statistical significance should include P values or 95% confidence intervals. The abstract should not include data that are not given in the full text.
In place of an abstract, a summary is required for Review Articles, Pictorial Essays, Technical Innovations, and Case Series. Content should adhere to the guidelines for abstracts but should not be divided into sections. It should not exceed 100 words and should give a brief overview of the article. Three to six key words should be provided at the end.
For Original Research articles, the full text of the manuscript should be divided into the following sections: Introduction, Materials and Methods, Results, and Discussion. For other articles, the text may be divided into sections if desired.
On a separate page preceding the references, contributions made by colleagues who are not authors of the paper should be acknowledged. This page should also include acknowledgments
of published material reproduced with permission, previous presentations of the work at meetings, related grant support received, and disclosures of relevant commercial interests.
Footnotes are to be used when referencing each of the following types of information: • Abstracts
• Conference presentations
• Online databases
• Personal communications
• Products, drugs, equipment, and other materials • Statistical and computer software
• Theses and dissertations
Specific products, equipment, or drugs should be included in the footnotes only if they were essential to the outcome of the report or study. Products, equipment, and drugs that are commonly used materials in veterinary medicine need not be footnoted.
Footnotes should be cited in the text as superscript letters and listed alphabetically after the Acknowledgments section and before the references. If more than 26 footnotes are required, continue the sequence with double letters (eg, aa, bb, and cc). For products and equipment, provide complete information in the footnote, including manufacturer’s name and location (ie, city, state, and country).
Each reference must be cited as (surname, year of publication) and listed in the alphabetical order. Duplicate references should not be listed; rather, subsequent citations of a reference should be listed only once. When more than 6 authors are included in a reference, et al replaces the names of all authors after the first 3. Inclusive page ranges should be given where applicable. Accepted work in press includes the journal title or the publisher if it is a book. Material not accepted for publication cannot be included as a reference and should be cited parenthetically in the text as unpublished data, including all participants’ initials and surnames and the year. Abbreviations of journal titles should conform to those used in the National Library of Medicine (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals). The style and punctuation of references should follow the formats illustrated by the following examples:
Journal Article With Up to 6 Authors
1. Luo W, Zhou X, Gong X, Zheng M, Zhang J, Guo X. Study of sequential histopathologic changes, apoptosis, and cell proliferation in rabbit livers after high- intensity focused ultrasound ablation. J Ultrasound Med 2007; 26:477–485.
Journal Article with More Than 6 Authors
2. Lamont LA, Bulmer BJ, Sisson DD, et al. Doppler echocardiographic effects of medetomidine on dynamic left ventricular outflow tract obstruction in cats. J Am Vet Med Assoc 2002;221:1276–1281.
Journal Article Published Online Ahead of Print
3. Cummisford K, Sundar S, Hagberg R, Mahmood F. Realtime three-dimensional transesophageal echocardiography and a congenital bilobar left atrial appendage [published online ahead of print June 24, 2009]. J Cardiothorac Vasc Anesth.doi:10.1053/j.jvca.2009.04.005.
Abstract of a Paper Presented at a Meeting
4. Shipp TD, Bromley B, Benacerraf BR. Comparison of the fundal endometrial diameters using 3-dimensional rendering for those with embedded and nonembedded intrauterine devices [abstract]. J Ultrasound Med 2009; 28(suppl):S47.
5. Cardenosa G. Breast Imaging. 1st ed. Philadelphia, PA: Lippincott Williams &
6. McGahan JP (ed). Interventional Ultrasound. Baltimore, MD: Williams & Wilkins;
Chapter in a Book
7. Muir P, Johnson KA, Manley PA. Fractures of the pelvis. In: Birchard SJ, Sherding RG, (eds). Saunders Manual of Small Animal Practice. 2nd ed. Philadelphia: WB Saunders Co, 2000;1126–1132.
8. Animal and Plant Health Inspection Service. Bovine spongiform encephalopathy (BSE). Available at: www.aphis.usda.gov/lpa/issues/bse/bse.html. Accessed Feb 18, 2003.
Tables must be numbered consecutively with Arabic numerals in the order in which they appear in the manuscript. Each table should appear on a separate page and should contain a title that includes the table number. No vertical lines or borders may appear in a table. Tables must contain all necessary information so that they may stand alone, independent of the text. Data given in the text should not be duplicated in tables. All tables must be cited in numerical order in the text. Tables should be included in the text document and should not be submitted as graphics.
For initial submissions, figure legends should be provided with their corresponding images at the end of the text document. Figures must be numbered consecutively with Arabic numerals in the order in which the figures appear in the article. All figures must be cited in numerical order in the text.
Abbreviations of common clinical and technical terms listed in the American Medical Association Manual of Style, 10th Edition, may be used if they appear 3 or more times in the full text and abstract/summary, respectively. Each abbreviation should be defined at first use in the full text and abstract/summary, respectively. Use of other abbreviations is discouraged unless they are essential to the clarity of the manuscript.
Additional materials that are not in themselves essential to the understanding of the article but provide an important expansion of the article contents may be submitted for publication as supplemental materials. Examples include extended descriptions of experimental methods, extended bibliographies, additional supporting data or results (eg, tables and figures), reporting checklists, copies of survey instruments or questionnaires, handouts, forms, and multimedia representations (eg, video clips) of relevant content.
Supplemental materials must be useful to readers and relevant to the article; redundant and extraneous content will not be accepted. Whether supplemental materials will be accepted for publication is solely at the discretion of the editors. Supplemental materials accepted for publication will not appear in the printed version of the journal but will be posted on the journal’s website. Ideally, supplemental materials will be sent with the manuscript to external
reviewers for peer review. Whether supplemental materials have or have not undergone peer review will be indicated on the landing page where the supplemental materials are posted. Supplemental materials should be prepared in compliance with the general guidelines for manuscript style. Although supplemental materials may undergo minor copy editing or formatting, they generally will not undergo the same substantive editing provided for manuscripts. Therefore, the authors are responsible for ensuring clarity and accuracy of the content.
MANUSCRIPT SUBMISSION PROCESS
New Manuscript Submissions
Submit manuscripts through the journal’s online system. To begin, go to Manuscript Submission Page at http//dergipark.gov.tr/tjvr
Prepare version 1 manuscripts as follows:
Cover Letter—Please supply along with your manuscript files and forms. Be sure to include the e-mail address of each listed author.
Text—Microsoft Word is preferred. All text should be double spaced, and all text elements, including tables, should be combined in a single document. Manuscripts should include continuous line numbering.
Images and Graphics—For initial submissions, please embed images into the text file at the end of the document. Please clearly label images and place the corresponding legend with each image.
Guidelines for Images
All figures should be embedded at the end of the manuscript with the name of the figure used as the file name (eg, Figure 1). Gray scale or black and white should be used; color should be used only when important information would otherwise be lost (eg, when certain tissue-staining patterns are poorly visible in gray scale or when a color-flow Doppler ultrasonogram is provided). For figures that include multiple panels, each panel should be sequentially labeled with a capital letter in the same corner of each panel. If a figure contains 2 or more rows of panels, the letter labels should be applied sequentially from left to right in the first row, then from left to right in the second row, and so on.
Permission to Reproduce Published Material
Written permission from the author and publisher of any previously published figure, table, or lengthy passage of text included in the manuscript must be submitted with the paper. If any form of preliminary publication, other than an abstract of no more than 400 words, has occurred or is contemplated, a reprint or manuscript of the actual or proposed preliminary publication should accompany the manuscript.
The intellectual content of the paper is the responsibility of the author; the editor and the TJVR accept no responsibility for the opinions and statements of authors. While every effort is made by the editor and editorial staff to avoid any inaccurate or misleading information, they accept no liability for the consequences of wrong information. The authors agree to keep the editor and publisher fully indemnified against any liability or claim that may arise from the publication of incorrect or misleading data.
INSTITUTIONAL REVIEW BOARD APPROVAL (ETHICAL REPORT) AND INFORMED CONSENT
With the exception of reports of retrospective studies based solely on reviews of medical records, manuscripts describing studies that involved the use of animals, including studies that involved the use of privately owned animals (eg, animals owned by clients, staff members, students, or private entities), must include a statement in the Methods section that the study protocol was reviewed and approved by an appropriate oversight entity (eg, an animal care and use committee or institutional review board) or was performed in compliance with institutional or other (eg, governmental or international) guidelines for research on animals.
Manuscripts describing prospective studies that involved privately owned animals must also include a statement indicating that informed owner consent was obtained. Manuscripts describing research involving human subjects must include a statement that the research was performed under appropriate institutional review board oversight.
For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. Manuscripts that do not comply with these rules will not be accepted for publication.
Accepted manuscripts will be copyedited to eliminate grammatical and typographical errors and to ensure conciseness and clarity. The corresponding author will receive proofs of the copyedited article before publication.
No part of this publication may be reproduced, stored or transmitted in any form or by any means without the prior permission in writing from the copyright holder. Authorization to copy items for internal and personal use is granted by the copyright holder for libraries and other
users registered. This consent does not extend to other kinds of copying such as copying for general distribution, for advertising or promotional purposes, for republication, for creating new collective works or for resale. Permissions for such reuse and other special requests can be obtained by addressing to: email@example.com
CONTACTING THE JOURNAL
The Turkish Journal of Veterinary Research Editorial Office may be contacted through the following:
Prof. Dr. Ebubekir CEYLAN
Turkish Journal of Veterinary Research
Ankara Üniversitesi Veteriner Fakültesi
İç Hastalıkları ABD
Dışkapı, 06110 Ankara, TURKEY
E-mail: firstname.lastname@example.org, email@example.com
Manuscripts are considered for publication with the understanding that they are submitted solely to the Turkish Journal of Veterinary Research and are not under consideration elsewhere.